down arrow

INVO BioScience, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US44984F4019
USD
1.54
-0.1 (-6.1%)

Dec 05

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
NanoVibronix, Inc.
Nuwellis, Inc.
Dynatronics Corp.
INVO BioScience, Inc.
Nexalin Technology, Inc.
Tivic Health Systems, Inc.
Bone Biologics Corp.
BIOLASE, Inc.
ThermoGenesis Holdings, Inc.
Motus GI Holdings, Inc.
Biocept, Inc.
Why is INVO BioScience, Inc. ?
1
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
  • Poor long term growth as Operating profit has grown by an annual rate -203.97% of over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -6.25
2
Flat results in Jun 25
  • NET PROFIT(9M) At USD -8.22 MM has Grown at -45.74%
  • OPERATING CASH FLOW(Y) Lowest at USD -6.53 MM
  • ROCE(HY) Lowest at -1,294.96%
3
Risky - Negative EBITDA
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -96.28%, its profits have fallen by -47.7%
4
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -96.28% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is INVO BioScience, Inc. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
INVO BioScience, Inc.
-95.05%
0.03
1165.17%
S&P 500
12.66%
0.96
19.87%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
42.16%
EBIT Growth (5y)
-178.75%
EBIT to Interest (avg)
-6.25
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.80
Sales to Capital Employed (avg)
0.66
Tax Ratio
0.10%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
19.93%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.13
EV to EBIT
-0.75
EV to EBITDA
-0.83
EV to Capital Employed
0.52
EV to Sales
1.04
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-69.23%
ROE (Latest)
-139.69%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

6What is working for the Company
NET PROFIT(HY)

Higher at USD -4.59 MM

INVENTORY TURNOVER RATIO(HY)

Highest at 21.4%

NET SALES(Q)

Highest at USD 1.86 MM

EPS(Q)

Highest at USD -9.44

-10What is not working for the Company
NET PROFIT(9M)

At USD -8.22 MM has Grown at -45.74%

OPERATING CASH FLOW(Y)

Lowest at USD -6.53 MM

ROCE(HY)

Lowest at -1,294.96%

RAW MATERIAL COST(Y)

Grown by 21.07% (YoY

CASH AND EQV(HY)

Lowest at USD 1.39 MM

Here's what is working for INVO BioScience, Inc.
Net Profit
Higher at USD -4.59 MM
than preceding 12 month period ended Jun 2025
MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (USD MM)

Inventory Turnover Ratio
Highest at 21.4% and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Net Sales
Highest at USD 1.86 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (USD MM)

EPS
Highest at USD -9.44
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Here's what is not working for INVO BioScience, Inc.
Operating Cash Flow
Lowest at USD -6.53 MM
in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)

Cash and Eqv
Lowest at USD 1.39 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Raw Material Cost
Grown by 21.07% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."